The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?-Reference-Cited by-同舟云学术

The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?

Published:2019-12-29 Issue:7 Volume:115 Page:1395-1403
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Ekhtiari Hamed¹²^ORCID,Noroozi Alireza¹³,Farhoudian Ali⁴⁵^ORCID,Radfar Seyed Ramin⁴⁶^ORCID,Hajebi Ahmad⁷,Sefatian Saeed⁸,Zare‐bidoky Mehran¹⁹,Razaghi Emran Mohammad⁵^ORCID,Mokri Azarakhsh¹⁵,Rahimi‐Movaghar Afarin¹^ORCID,Rawson Richard⁶¹⁰

Affiliation:

1. Iranian National Center for Addiction Studies (INCAS)Tehran University of Medical Sciences (TUMS) Tehran Iran

2. Laureate Institute for Brain Research Tulsa OK USA

3. Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine (SATiM)Tehran University of Medical Sciences (TUMS) Tehran Iran

4. Substance Abuse and Dependence Research CenterUniversity of Social Welfare and Rehabilitation Sciences Tehran Iran

5. Department of PsychiatryTehran University of Medical Sciences Tehran Iran

6. Integrated Substance Abuse ProgramsUniversity of California at Los Angeles Los Angeles CA USA

7. Research Center for Addiction and Risky Behaviors (ReCARB), Psychiatric DepartmentIran University of Medical Sciences Tehran Iran

8. Demand Reduction Work Group, Expediency Discernment Council of Islamic Republic of Iran Tehran Iran

9. School of Medicine, Shahid‐Sadoughi University of Medical Sciences Yazd Iran

10. Center for Behavior and HealthUniversity of Vermont Burlington VT USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14905

Reference61 articles.

1. The World Bank data: World Bank2019. Available at:https://data.worldbank.org/country/iran-islamic-rep(accessed date 14 November 2019).

2. Country profile: IMUNA2019. Available at:https://imuna.org/resources/country-profiles/iran-islamic-republic(accessed date November 14 2019).

3. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey

4. Drug policy and the public good: evidence for effective interventions

5. Drug Policy and the Public Good: a summary of the second edition

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys;Harm Reduction Journal;2024-08-14

2. The Trend of Poisoning During the COVID-19 and Post-COVID-19 Era in Tehran, Iran Between 2019 and 2023;INT J MED TOX FORENS;2024

3. Non-fatal Overdose Prevalence and Associated Factors among People Who Inject Drugs in Iran;International Journal of Mental Health and Addiction;2024-07-17

4. Self-Reported Methamphetamine Use Versus Biological Testing Among Treatment-Seeking Patients;Iranian Journal of Psychiatry and Behavioral Sciences;2024-07-17

5. International perspectives on opioid use disorder and treatment: Results from an online convenience sample;Heroin Addiction and Related Clinical Problems;2024-03